Fellowship · San Diego, CA
Sponsored by University of California (San Diego) Medical Center
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
The New England journal of medicine · 2024 · 761 citations · Cynthia Behling
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
The New England journal of medicine · 2021 · 954 citations · Cynthia Behling
Global, regional, and national trends in under-5 mortality between 1990 and 2019 with scenario-based projections until 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation.
The Lancet. Global health · 2022 · 341 citations · Emi Suzuki
Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.
Lancet (London, England) · 2021 · 380 citations · Emi Suzuki
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
Journal of hepatology · 2023 · 262 citations · Cynthia Behling
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Journal of hepatology · 2021 · 476 citations · Ariel Feldstein
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
The New England journal of medicine · 2025 · 102 citations · Cynthia Behling
Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: A retrospective cohort study.
Hepatology (Baltimore, Md.) · 2026 · 35 citations · Jeffrey Schwimmer, Nidhi Goyal, Kimberly Newton, Elizabeth Yu, Cynthia Behling